21 CFR Part 210

21 CFR Part 210 is a set of regulations established by the U.S. Food and Drug Administration (FDA) that outlines current Good Manufacturing Practices (cGMP) for the production of pharmaceuticals. It specifies standards to ensure drugs are consistently produced and controlled to quality standards, including proper facility design, equipment, sanitation, personnel training, and documentation. The goal is to ensure drug safety, effectiveness, and quality throughout manufacturing, preventing contamination, mix-ups, and errors. These guidelines help manufacturers maintain high-quality processes and transparency, ultimately protecting public health.